日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Next-generation FVIIIa-mimetic bispecific antibody NXT007: evaluation in preclinical models of hemostasis and thrombosis

新一代FVIIIa模拟双特异性抗体NXT007:在止血和血栓形成临床前模型中的评估

Locke, Matthew; Albiez, Jamie; Receveur, Nicolas; Marbach, Sandra; Frey, Nina; Girotra, Mukul; Wyssenbach, Mariella; Bektic, Lejla; David, Tovo

Integration of Darolutamide in the Treatment Landscape for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Network Meta-analysis of Efficacy and Safety

达罗鲁胺在转移性激素敏感性前列腺癌治疗中的应用:疗效和安全性的系统评价和网络荟萃分析

Melchior, Felix; Koett, Magdalena; Keller, Felix; Artamonova, Nastasiia; Giannini, Giulia; Kafka, Mona; Ladurner, Michael; Neuwirt, Hannes; Bektic, Jasmin; Horninger, Wolfgang; Heidegger, Isabel

Association of CMTM6 expression with clinicopathological characteristics and prognostic implications in renal cell carcinoma

CMTM6表达与肾细胞癌的临床病理特征及预后意义的相关性

Tulchiner, Gennadi; Fritz, Josef; Rehder, Peter; Bektic, Jasmin; Zelger, Bettina; Jelisejevas, Lukas; Brunner, Andrea; Ladurner, Michael

Use of (177)Lu prostate-specific membrane antigen therapy in metastatic castration-resistant prostate cancer : Joint statement of the Austrian Society of Nuclear Medicine and Theranostics and the Austrian Society of Urology and Andrology

(177)Lu前列腺特异性膜抗原疗法在转移性去势抵抗性前列腺癌中的应用:奥地利核医学与治疗诊断学会和奥地利泌尿男科学会的联合声明

Mirzaei, Siroos; Schweighofer-Zwink, Gregor; Ofner, Heidemarie; Bektic, Jasmin; Fajkovic, Harun; von Guggenberg, Eisabeth; Ponholzer, Anton; Kramer, Gero; Lusuardi, Lukas; Gabriel, Michael; Traub-Weidinger, Tatjana; Hacker, Marcus; Shariat, Shahrokh F

Efficacy and safety of rechallenge with [(177)Lu]Lu-PSMA-I&T radioligand therapy in metastatic castration resistant prostate cancer

转移性去势抵抗性前列腺癌再次使用[(177)Lu]Lu-PSMA-I&T放射性配体疗法的疗效和安全性

Santo, Giulia; Di Santo, Gianpaolo; Sviridenko, Anna; Bayerschmidt, Steffen; Wirth, Lukas; Scherbauer, Fabian; Lehmann, Peter; von Guggenberg, Elisabeth; Decristoforo, Clemens; Heidegger-Pircher, Isabel; Bektic, Jasmin; Virgolini, Irene

Patients' anxieties and fears: a comparison between transrectal prostate biopsy and prostate MRI

患者的焦虑和恐惧:经直肠前列腺活检与前列腺MRI的比较

Steinkohl, Fabian; Luger, Anna K; Gruber, Leonhard; Pichler, Renate; Heidegger, Isabel; Bektic, Jasmin; Aigner, Friedrich

Real-world comparison of Docetaxel versus new hormonal agents in combination with androgen-deprivation therapy in metastatic hormone-sensitive prostate cancer descrying PSA Nadir ≤ 0.05 ng/ml as marker for treatment response

一项真实世界研究比较了多西他赛与新型激素药物联合雄激素剥夺疗法治疗转移性激素敏感性前列腺癌的疗效,并将PSA最低值≤0.05 ng/ml作为治疗反应的标志物。

Kafka, Mona; Burtscher, Thomas; Fritz, Josef; Schmitz, Maximilian; Bektic, Jasmin; Ladurner, Michael; Horninger, Wolfgang; Heidegger, Isabel

Transurethral resection of the prostate in 85+ patients: a retrospective, multicentre study

85例以上患者经尿道前列腺切除术:一项回顾性多中心研究

Lotterstätter, Michael; Seklehner, Stephan; Wimpissinger, Florian; Gombos, Jozsef; Bektic, Jasmin; Stolzlechner, Philipp; Laimer, Sarah; Herrmann, Thomas R W; Madersbacher, Stephan; Lusuardi, Lukas; Sieberer, Manuela; Ramesmayer, Christian

Validation of Cell-Free RNA and Circulating Tumor Cells for Molecular Marker Analysis in Metastatic Prostate Cancer

利用游离RNA和循环肿瘤细胞进行转移性前列腺癌分子标志物分析的验证

Michael Ladurner ,Manuel Wieser ,Andrea Eigentler ,Martin Seewald ,Gabriele Dobler ,Hannes Neuwirt ,Mona Kafka ,Isabel Heidegger ,Wolfgang Horninger ,Jasmin Bektic ,Helmut Klocker ,Peter Obrist ,Iris E Eder

A real-world comparison of docetaxel versus abiraterone acetate for metastatic hormone-sensitive prostate cancer

多西他赛与醋酸阿比特龙治疗转移性激素敏感性前列腺癌的真实世界比较

Tsaur, Igor; Heidegger, Isabel; Bektic, Jasmin; Kafka, Mona; van den Bergh, Roderick C N; Hunting, Jarmo C B; Thomas, Anita; Brandt, Maximilian P; Höfner, Thomas; Debedde, Eliott; Thibault, Constance; Ermacora, Paola; Zattoni, Fabio; Foti, Silvia; Kretschmer, Alexander; Ploussard, Guillaume; Rodler, Severin; von Amsberg, Gunhild; Tilki, Derya; Surcel, Christian; Rosenzweig, Barak; Gadot, Moran; Gandaglia, Giorgio; Dotzauer, Robert